<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
43913-403-16
</NDCCode>
<PackageDescription>
474 mL in 1 BOTTLE (43913-403-16)
</PackageDescription>
<NDC11Code>
43913-0403-16
</NDC11Code>
<ProductNDC>
43913-403
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
G-bronco-d
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Guaifenesin, Dextromethorphan Hydrobromide, And Phenylephrine Hydrochloride
</NonProprietaryName>
<DosageFormName>
SUSPENSION
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20120701
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH FINAL
</MarketingCategoryName>
<ApplicationNumber>
part341
</ApplicationNumber>
<LabelerName>
MCLAREN MEDICAL INC
</LabelerName>
<SubstanceName>
GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
200; 10; 5
</StrengthNumber>
<StrengthUnit>
mg/5mL; mg/5mL; mg/5mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2019-09-21
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
E
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20171231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>